Tenax Therapeutics (TENX) EPS (Basic): 2010-2016
Historic EPS (Basic) for Tenax Therapeutics (TENX) over the last 3 years, with Dec 2016 value amounting to -$1.20.
- Tenax Therapeutics' EPS (Basic) rose 99.99% to -$1.20 in Q4 2016 from the same period last year, while for Dec 2016 it was -$13,771, marking a year-over-year increase of 0.03%. This contributed to the annual value of -$1.15 for FY2024, which is 96.30% up from last year.
- According to the latest figures from Q4 2016, Tenax Therapeutics' EPS (Basic) is -$1.20, which was down 700.00% from -$0.15 recorded in Q3 2016.
- Tenax Therapeutics' EPS (Basic)'s 5-year high stood at -$0.05 during Q4 2012, with a 5-year trough of -$13,770 in Q4 2015.
- Its 2-year average for EPS (Basic) is -$2,754, with a median of -$0.21 in 2015.
- As far as peak fluctuations go, Tenax Therapeutics' EPS (Basic) tumbled by 9,558.33% in 2012, and later spiked by 99.99% in 2016.
- Tenax Therapeutics' EPS (Basic) (Quarterly) stood at -$0.05 in 2012, then surged by 47.80% to -$6.05 in 2013, then reached -$13,770 in 2015, then soared by 99.99% to -$1.20 in 2016.
- Its EPS (Basic) stands at -$1.20 for Q4 2016, versus -$0.15 for Q3 2016 and -$0.19 for Q2 2016.